Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients-Reference-Cited by-同舟云学术

Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients

Published:2014-09-09 Issue:2 Volume:38 Page:143-147
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

de Luis D. A.,Aller R.,Izaola O.,Bachiller R.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s40618-014-0161-y.pdf

Reference23 articles.

1. Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20:876–913

2. Holst JJ (2002) Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes/Metab Res Rev 18:430–441

3. Bullock BP, Heller RS, Habener JF (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968–2978

4. Thorens B (1992) Expression cloning of the pancreatic beta-cell receptor for the gluco-incretin hormone glucagon peptide-1. Proc Natl Acad Sci USA 89:8641–8645

5. Scrocchi LA, Brown N, MacLusky N (1996) Glucose intolerance but normal satiety in mice with a null mutation in the GLP-1R gene. Nat Med 2:1254–1258

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP1R rs3765467 Polymorphism Is Associated with the Risk of Early Onset Type 2 Diabetes;International Journal of Endocrinology;2023-12-14

2. Polymorphisms in the glucagon-like peptide-1 receptor gene and their interactions on the risk of osteoporosis in postmenopausal Chinese women;PLOS ONE;2023-12-14

3. Association between GLP-1R gene polymorphism and dyslipidemia in Chinese patients with type 2 diabetes mellitus: A case-control study;Gene;2023-08

4. Potential contributors to variation in weight‐loss response to liraglutide;Obesity Reviews;2023-04-17

5. Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes;Frontiers in Endocrinology;2023-01-23